Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Research shows why some heart failure treatments fail

Do the biological underpinnings of heart failure share more in common with cancerous tumors than other cardiovascular diseases?

12 Nov 2008

Nanomatrix stent coating designed to mimic natural endothelium

A nanomatrix for stent coating designed at the University of Alabama at Birmingham (UAB) mimics natural endothelium, the substance that lines blood vessels, and promises the potential to prevent post-operative tissue scaring along the blood vessel wall, greatly reducing the possibility of future thrombosis, or blockage at the stent site.

11 Nov 2008

VIA Pharmaceuticals announces results of phase 2 trials of VIA-2291 in cardiovascular disease

VIA Pharmaceuticals, Inc. has announced the results of two Phase 2 studies of its lead drug, VIA-2291.

10 Nov 2008

Heart attack prevention within three months after hospitalization significantly averted future attacks

Despite substantial progress in the diagnosis and treatment of heart attack patients, prevention of recurrent heart attacks continues to be a major clinical challenge.

10 Nov 2008

Study compares survival following different heart disease treatments in patients with ESRD

For patients with end stage renal disease (ESRD) on dialysis who also must be treated for heart disease, stents provide the best one-year survival compared with other revascularization treatments, but bypass surgery provides the best long-term survival, according to a paper being presented at the American Society of Nephrology's 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania.

7 Nov 2008

FDA approves Ranexa for the treatment of chronic angina

CV Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved a new, first line indication for Ranexa(R) (ranolazine extended-release tablets) for the treatment of chronic angina.

7 Nov 2008

Age, race are among factors that influence carotid-surgery success

Advanced age and race are among the factors that can affect whether a patient dies or suffers a stroke after carotid-artery surgery, a UT Southwestern Medical Center physician involved in a multicenter study has found.

6 Nov 2008

Review of health benefits of grape polyphenols

A growing body of research data suggests that consuming foods rich in polyphenols from grapes - including red wine - helps reduce the risk of heart disease, according to a review article in the November issue of Nutrition Research.

28 Oct 2008

Eating whole grains lowers heart failure risk

About 5 million people in the United States suffer from heart failure (HF). While some reports indicate that changes to diet can reduce HF risk, few large, prospective studies have been conducted.

27 Oct 2008

Developing depression after a heart attack increases one’s risk of death or readmission

Science has found many links between depression and other serious medical illnesses, such as cancer, stroke, diabetes, and heart disease. For example, people who develop depression following a heart attack (myocardial infarction) or chest pain (angina) have an elevated risk of cardiac death or hospital readmission over the following year.

22 Oct 2008

Vulnerable plaque may be easier to detect through optical coherence tomography

Research results indicate that optical coherence tomography (OCT), a newly evolving imaging method, may be the best tool available to detect vulnerable plaque in coronary arteries. The findings will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).

12 Oct 2008

Depressed dialysis patients more likely to be hospitalized or die, researcher finds

Dialysis patients diagnosed with depression are nearly twice as likely to be hospitalized or die within a year than those who are not depressed, a UT Southwestern Medical Center researcher has found.

14 Sep 2008

Overcoming poor response to standard oral antiplatelet agents

Existing practice surrounding many cardiovascular medications, including anti-hypertensive and lipid-lowering agents, is based on the evaluation of response to therapy. In cases where ideal therapeutic targets (which have been identified through several previous studies) are not met in the single individual, there is evidence to support the need to intensify standard treatment so as to achieve better control of the cardiovascular risk factor under treatment (e.g. blood pressure or cholesterol levels) as this translates into a better outcome.

2 Sep 2008

Results from the Simvastatin and Ezetimibe in aortic stenosis study

The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study has investigated the effects of intensive cholesterol lowering with the combination of simvastatin (40 mg daily) and ezetimibe (10 mg daily) in patients with aortic stenosis.

2 Sep 2008

New biomarkers in acute cardiac care

In conjunction with clinical assessment and the ECG, simple and rapid blood tests have become the standard for the detection of myocardial infarction. Starting in the year 2000, recommendations by the European Society of Cardiology and other major cardiology societies worldwide have begun to state uniformly that a rise in cardiac troponins - sensitive and specific markers for dying cells in the heart - is a prerequisite for the clinical diagnosis of myocardial infarction.

1 Sep 2008

Sex hormones link to heart risk

Men are more prone to - and likely to die of - heart disease compared with women of a similar age - and sex hormones are to blame, according to a new University of Leicester led study.

1 Sep 2008

Issues on cholesterol: diet, statins and genetics

Genetic lipoprotein disorders are frequently seen in patients with premature coronary artery disease (CAD). An example of strong genetic predisposition is the disorder: familial hypercholesterolemia, where a single gene defect (the low density lipoprotein receptor) contributes to most of the familial expression of CAD.

1 Sep 2008

Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery

The DECREASE III Study which took place in the Netherlands between June 2004 and April 2008, showed that patients treated with Fluvastatin showed an improved cardiac outcome after surgery.

1 Sep 2008

New generation drug-eluting stent demonstrates equivalent efficacy to market leader in 'real world'

In the first study of its kind, a drug-eluting stent (DES) with a biodegradable polymer applied only to the outer surface has been demonstrated as safe and effective as one of the most established and widely used types of DES with a durable polymer, in equivalent conditions to everyday clinical practice.

1 Sep 2008

Faster heart rate linked to increased heart attack risk

A long-term study has revealed a link between a faster heart rate and the risk of a heart attack and the researchers say that heart disease patients with a pulse of more than 70 beats a minute are most at risk.

1 Sep 2008

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Research shows why some heart failure treatments fail

Nanomatrix stent coating designed to mimic natural endothelium

VIA Pharmaceuticals announces results of phase 2 trials of VIA-2291 in cardiovascular disease

Heart attack prevention within three months after hospitalization significantly averted future attacks

Study compares survival following different heart disease treatments in patients with ESRD

FDA approves Ranexa for the treatment of chronic angina

Age, race are among factors that influence carotid-surgery success

Review of health benefits of grape polyphenols

Eating whole grains lowers heart failure risk

Developing depression after a heart attack increases one’s risk of death or readmission

Vulnerable plaque may be easier to detect through optical coherence tomography

Depressed dialysis patients more likely to be hospitalized or die, researcher finds

Overcoming poor response to standard oral antiplatelet agents

Results from the Simvastatin and Ezetimibe in aortic stenosis study

New biomarkers in acute cardiac care

Sex hormones link to heart risk

Issues on cholesterol: diet, statins and genetics

Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery

New generation drug-eluting stent demonstrates equivalent efficacy to market leader in 'real world'

Faster heart rate linked to increased heart attack risk

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in